Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of β-amyloid plaques in Alzheimer's brains

Journal of Medicinal Chemistry

Volumn 54, Issue 8, 2011, Pages 2971-2979

  Ono, Masahiro ^a   Cheng, Yan ^a   Kimura, Hiroyuki ^a   Cui, Mengchao ^a   Kagawa, Shinya ^b   Nishii, Ryuichi ^b   Saji, Hideo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Shiga Medical Center Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BENZOFURAN DERIVATIVE; FLUORINE 18; AMYLOID BETA PROTEIN; DIAGNOSTIC AGENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; AUTOPSY; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; ANIMAL; BRAIN; HUMAN; MASS SPECTROMETRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TISSUE DISTRIBUTION;

AMYLOID BETA-PEPTIDES; ANIMALS; BENZOFURANS; BRAIN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; POSITRON-EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION;

EID: 79955409570     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm200057u     Document Type: Article

References (46)

1. Hardy, J. A.; Higgins, G. A. Alzheimer's disease: the amyloid cascade hypothesis Science 1992, 256, 184-185
2. Selkoe, D. J. Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 2001, 81, 741-766 (Pubitemid 32267077)
3. Selkoe, D. J. Imaging Alzheimer's amyloid Nat. Biotechnol. 2000, 18, 823-824 (Pubitemid 30640902)
4. Mathis, C. A.; Wang, Y.; Klunk, W. E. Imaging β-amyloid plaques and neurofibrillary tangles in the aging human brain Curr. Pharm. Des. 2004, 10, 1469-1492 (Pubitemid 38559761)
5. Nordberg, A. PET imaging of amyloid in Alzheimer's disease Lancet Neurol. 2004, 3, 519-527 (Pubitemid 39485859)
6. 11C-labeled stilbene derivatives as Aβ-aggregate-specific PET imaging agents for Alzheimer's disease Nucl. Med. Biol. 2003, 30, 565-571 (Pubitemid 37289318)
7. 11C]SB-13 PET Am. J. Geriatr. Psychiatry 2004, 12, 584-595 (Pubitemid 41031060)
8. 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents J. Med. Chem. 2003, 46, 2740-2754 (Pubitemid 36702542)
9. Klunk, W. E.; Engler, H.; Nordberg, A.; Wang, Y.; Blomqvist, G.; Holt, D. P.; Bergstrom, M.; Savitcheva, I.; Huang, G. F.; Estrada, S.; Ausen, B.; Debnath, M. L.; Barletta, J.; Price, J. C.; Sandell, J.; Lopresti, B. J.; Wall, A.; Koivisto, P.; Antoni, G.; Mathis, C. A.; Langstrom, B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B Ann. Neurol. 2004, 55, 306-319 (Pubitemid 38269583)
10. Kudo, Y.; Okamura, N.; Furumoto, S.; Tashiro, M.; Furukawa, K.; Maruyama, M.; Itoh, M.; Iwata, R.; Yanai, K.; Arai, H. 2-(2-[2-Dimethylaminothiazol-5-yl] ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients J. Nucl. Med. 2007, 48, 553-561 (Pubitemid 47571409)
11. Johnson, A. E.; Jeppsson, F.; Sandell, J.; Wensbo, D.; Neelissen, J. A.; Jureus, A.; Strom, P.; Norman, H.; Farde, L.; Svensson, S. P. AZD2184: a radioligand for sensitive detection of β-amyloid deposits J. Neurochem. 2009, 108, 1177-1186
12. 11C-PET imaging agents for β-amyloid plaques Bioorg. Med. Chem. Lett. 2010, 20, 1976-1980
13. Agdeppa, E. D.; Kepe, V.; Liu, J.; Flores-Torres, S.; Satyamurthy, N.; Petric, A.; Cole, G. M.; Small, G. W.; Huang, S. C.; Barrio, J. R. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer's disease J. Neurosci. 2001, 21, RC189
14. Shoghi-Jadid, K.; Small, G. W.; Agdeppa, E. D.; Kepe, V.; Ercoli, L. M.; Siddarth, P.; Read, S.; Satyamurthy, N.; Petric, A.; Huang, S. C.; Barrio, J. R. Localization of neurofibrillary tangles and β-amyloid plaques in the brains of living patients with Alzheimer disease Am. J. Geriatr. Psychiatry 2002, 10, 24-35 (Pubitemid 34052900)
15. 18F-GE067: a radioligand for in vivo brain amyloid imaging J. Nucl. Med. 2009, 50, 818-822
16. 18F-Flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial Ann. Neurol. 2010, 68, 319-329
17. 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease J. Nucl. Med. 2009, 50, 1251-1259
18. Zhang, W.; Oya, S.; Kung, M. P.; Hou, C.; Maier, D. L.; Kung, H. F. F-18 polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain Nucl. Med. Biol. 2005, 32, 799-809 (Pubitemid 41505313)
19. 18F-BAY94-9172, a novel PET tracer: proof of mechanism Lancet Neurol. 2008, 7, 129-135
20. 18F-BAY94-9172 J. Nucl. Med. 2009, 50, 309-315
21. 18F-Labeled styrylpyridines as PET agents for amyloid plaque imaging Nucl. Med. Biol. 2007, 34, 89-97 (Pubitemid 46038150)
22. 18F-AV-45: a PET agent for Aβ plaques in the brain J. Nucl. Med. 2009, 50, 1887-1894
23. 18F-AV-45 (flobetapir F 18) J. Nucl. Med. 2010, 51, 913-920
24. 18F]AV-45: a new PET imaging agent for Alzheimer's disease Appl. Radiat. Isot. 2010, 68, 2293-2297
25. 18F]AV-45, a novel amyloid imaging agent-a pilot study Nucl. Med. Biol. 2010, 37, 497-508
26. Clark, C. M.; Schneider, J. A.; Bedell, B. J.; Beach, T. G.; Bilker, W. B.; Mintun, M. A.; Pontecorvo, M. J.; Hefti, F.; Carpenter, A. P.; Flitter, M. L.; Krautkramer, M. J.; Kung, H. F.; Coleman, R. E.; Doraiswamy, P. M.; Fleisher, A. S.; Sabbagh, M. N.; Sadowsky, C. H.; Reiman, P. E.; Zehntner, S. P.; Skovronsky, D. M. Use of florbetapir-PET for imaging β-amyloid pathology J. Am. Med. Assoc. 2011, 305, 275-283
27. 18F stilbenes and styrylpyridines for PET imaging of Aβ plaques in Alzheimer's disease: a miniperspective J. Med. Chem. 2010, 53, 933-941
28. Ono, M.; Kung, M. P.; Hou, C.; Kung, H. F. Benzofuran derivatives as Aβ-aggregate-specific imaging agents for Alzheimer's disease Nucl. Med. Biol. 2002, 29, 633-642 (Pubitemid 35266662)
29. Ono, M.; Kawashima, H.; Nonaka, A.; Kawai, T.; Haratake, M.; Mori, H.; Kung, M. P.; Kung, H. F.; Saji, H.; Nakayama, M. Novel benzofuran derivatives for PET imaging of β-amyloid plaques in Alzheimer's disease brains J. Med. Chem. 2006, 49, 2725-2730
30. Cheng, Y.; Ono, M.; Kimura, H.; Kagawa, S.; Nishii, R.; Kawashima, H.; Saji, H. Fluorinated benzofuran derivatives for PET imaging of β-amyloid plaques in Alzheimer's disease brains ACS Med. Chem. Lett. 2010, 1, 321-325
31. Ono, M.; Yoshida, N.; Ishibashi, K.; Haratake, M.; Arano, Y.; Mori, H.; Nakayama, M. Radioiodinated flavones for in vivo imaging of β-amyloid plaques in the brain J. Med. Chem. 2005, 48, 7253-7260 (Pubitemid 41743639)
32. Ono, M.; Haratake, M.; Mori, H.; Nakayama, M. Novel chalcones as probes for in vivo imaging of β-amyloid plaques in Alzheimer's brains Bioorg. Med. Chem. 2007, 15, 6802-6809 (Pubitemid 47385239)
33. 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains Bioorg. Med. Chem. Lett. 2010, 20, 6141-6144
34. Miyaura, N.; Yamada, K.; Suzuki, A. A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides Tetrahedron Lett. 1979, 36, 3437-3440
35. Ono, M.; Haratake, M.; Saji, H.; Nakayama, M. Development of novel β-amyloid probes based on 3,5-diphenyl-1,2,4-oxadiazole Bioorg. Med. Chem. 2008, 16, 6867-6872
36. Watanabe, H.; Ono, M.; Ikeoka, R.; Haratake, M.; Saji, H.; Nakayama, M. Synthesis and biological evaluation of radioiodinated 2,5-diphenyl-1,3,4- oxadiazoles for detecting β-amyloid plaques in the brain Bioorg. Med. Chem. 2009, 17, 6402-6406
37. Kung, H. F.; Lee, C. W.; Zhuang, Z. P.; Kung, M. P.; Hou, C.; Plossl, K. Novel stilbenes as probes for amyloid plaques J. Am. Chem. Soc. 2001, 123, 12740-12741 (Pubitemid 33140424)
38. Ono, M.; Haratake, M.; Nakayama, M.; Kaneko, Y.; Kawabata, K.; Mori, H.; Kung, M. P.; Kung, H. F. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease Nucl. Med. Biol. 2005, 32, 329-335 (Pubitemid 40692683)
39. Ono, M.; Watanabe, R.; Kawashima, H.; Cheng, Y.; Kimura, H.; Watanabe, H.; Haratake, M.; Saji, H.; Nakayama, M. Fluoro-pegylated chalcones as positron emission tomography probes for in vivo imaging of β-amyloid plaques in Alzheimer's disease J. Med. Chem. 2009, 52, 6394-6401
40. Maya, Y.; Ono, M.; Watanabe, H.; Haratake, M.; Saji, H.; Nakayama, M. Novel radioiodinated aurones as probes for SPECT imaging of β-amyloid plaques in the brain Bioconjugate Chem. 2009, 20, 95-101
41. Hsiao, K.; Chapman, P.; Nilsen, S.; Eckman, C.; Harigaya, Y.; Younkin, S.; Yang, F.; Cole, G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice Science 1996, 274, 99-102 (Pubitemid 26332733)
42. Ono, M.; Hayashi, S.; Kimura, H.; Kawashima, H.; Nakayama, M.; Saji, H. Push-pull benzothiazole derivatives as probes for detecting β-amyloid plaques in Alzheimer's brains Bioorg. Med. Chem. 2009, 17, 7002-7007
43. 18F-Labeled flavones for in vivo imaging of β-amyloid plaques in Alzheimer's brains Bioorg. Med. Chem. 2009, 17, 2069-2076
44. 11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease Eur. J. Nucl. Med. Mol. Imaging 2005, 32, 593-600 (Pubitemid 41214203)
45. Cheng, Y.; Prusoff, W. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 1973, 22, 3099-3108
46. oct from structures Chem. Rev. 1993, 93, 1281-1306